These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24672252)

  • 1. Comparative effectiveness of liraglutide in the treatment of type 2 diabetes.
    Rigato M; Fadini GP
    Diabetes Metab Syndr Obes; 2014; 7():107-20. PubMed ID: 24672252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
    Montanya E; Sesti G
    Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide: a review of its use in the management of type 2 diabetes mellitus.
    Perry CM
    Drugs; 2011 Dec; 71(17):2347-73. PubMed ID: 22085389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies of liraglutide, a novel, once-daily human glucagon-like peptide-1 analog for improved management of type 2 diabetes mellitus.
    Drab SR
    Pharmacotherapy; 2009 Dec; 29(12 Pt 2):43S-54S. PubMed ID: 19947816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide: a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes mellitus.
    Joffe D
    Am J Health Syst Pharm; 2010 Aug; 67(16):1326-36. PubMed ID: 20689121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes.
    Neumiller JJ; Sonnett TE; Wood LD; Setter SM; Campbell RK
    Diabetes Metab Syndr Obes; 2010 Jul; 3():215-26. PubMed ID: 21437090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from the Liraglutide Clinical Development Program--the Liraglutide Effect and Action in Diabetes (LEAD) studies.
    McGill JB
    Postgrad Med; 2009 May; 121(3):16-25. PubMed ID: 19491536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide in the treatment of Type 2 diabetes: clinical data and practical considerations for its use.
    Ampudia-Blasco FJ; Gómez CC; Claramunt XC; Alegría JG; Gimeno EJ; Bravo JJM; Raya PM; Pérez JN; Domingo MP
    Expert Rev Endocrinol Metab; 2010 Nov; 5(6):799-807. PubMed ID: 30780828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide: a new treatment for type 2 diabetes.
    Vilsboll T
    Drugs Today (Barc); 2009 Feb; 45(2):101-13. PubMed ID: 19343230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liraglutide: a review of its use in type 2 diabetes mellitus.
    Croom KF; McCormack PL
    Drugs; 2009 Oct; 69(14):1985-2004. PubMed ID: 19747013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies.
    Blonde L; Russell-Jones D
    Diabetes Obes Metab; 2009 Dec; 11 Suppl 3():26-34. PubMed ID: 19878259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide: A review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitus.
    Dharmalingam M; Sriram U; Baruah MP
    Indian J Endocrinol Metab; 2011 Jan; 15(1):9-17. PubMed ID: 21584160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pearls for initiating and utilizing liraglutide in patients with type 2 diabetes.
    Gross B
    J Pharm Pract; 2013 Apr; 26(2):144-50. PubMed ID: 23204146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists.
    Ard J; Fitch A; Fruh S; Herman L
    Adv Ther; 2021 Jun; 38(6):2821-2839. PubMed ID: 33977495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide: a review of its use in adult patients with type 2 diabetes mellitus.
    Scott LJ
    Drugs; 2014 Dec; 74(18):2161-74. PubMed ID: 25367717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.
    Guyton J; Jeon M; Brooks A
    Am J Health Syst Pharm; 2019 Oct; 76(21):1739-1748. PubMed ID: 31612934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liraglutide Effect and Action in Diabetes (LEAD™) trial.
    Madsbad S
    Expert Rev Endocrinol Metab; 2009 Mar; 4(2):119-129. PubMed ID: 30780853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the short-term cost-effectiveness of liraglutide versus sitagliptin in patients with type 2 diabetes failing metformin monotherapy in the United States.
    Langer J; Hunt B; Valentine WJ
    J Manag Care Pharm; 2013 Apr; 19(3):237-46. PubMed ID: 23537458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide in type 2 diabetes: from pharmacological development to clinical practice.
    Rossi MC; Nicolucci A
    Acta Biomed; 2009 Aug; 80(2):93-101. PubMed ID: 19848045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.